Financial News
Articles published by PerkinElmer, Inc.
![](https://www.businesswire.com/images/bwlogo_extreme.png)
PerkinElmer Board Declares Quarterly Dividend
April 25, 2023
From PerkinElmer, Inc.
Via Business Wire
Tickers
PKI
![](https://mms.businesswire.com/media/20230313005266/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
PerkinElmer Completes Divestiture of its Applied, Food and Enterprise Services Businesses
March 13, 2023
From PerkinElmer, Inc.
Via Business Wire
Tickers
PKI
![](https://mms.businesswire.com/media/20230224005190/en/1721865/22/EnVision_Nexus_by_PerkinElmer.jpg)
PerkinElmer Launches EnVison Nexus Multimode Plate Reader to Drive Improved Research and Discovery Workflows
February 24, 2023
From PerkinElmer, Inc.
Via Business Wire
Tickers
PKI
![](https://mms.businesswire.com/media/20230222005119/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
PerkinElmer to Present at Upcoming Investor Conferences
February 22, 2023
From PerkinElmer, Inc.
Via Business Wire
Tickers
PKI
![](https://mms.businesswire.com/media/20230214005052/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year of 2022
February 14, 2023
From PerkinElmer, Inc.
Via Business Wire
Tickers
PKI
![](https://mms.businesswire.com/media/20230126005743/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
PerkinElmer Board Declares Quarterly Dividend
January 26, 2023
From PerkinElmer, Inc.
Via Business Wire
Tickers
PKI
![](https://mms.businesswire.com/media/20221118005604/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
PerkinElmer Helps Accelerate Gene Therapy Research with Industry-First Ready-to-Use Viral Vector Assays
November 21, 2022
From PerkinElmer, Inc.
Via Business Wire
Tickers
PKI
![](https://www.businesswire.com/images/bwlogo_extreme.png)
PerkinElmer Announces Financial Results for the Third Quarter of 2022
November 08, 2022
From PerkinElmer, Inc.
Via Business Wire
Tickers
PKI
![](https://mms.businesswire.com/media/20221026005219/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
PerkinElmer Board Declares Quarterly Dividend
October 26, 2022
From PerkinElmer, Inc.
Via Business Wire
Tickers
PKI
![](https://mms.businesswire.com/media/20221017005178/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
PerkinElmer to Hold Earnings Call on Tuesday, November 8, 2022; Updates Third Quarter Outlook
October 17, 2022
From PerkinElmer, Inc.
Via Business Wire
Tickers
PKI
![](https://mms.businesswire.com/media/20220926005402/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
PerkinElmer Unveils Industry-first Cell Analysis Solution to Streamline Cell and Gene Therapy Research and Manufacturing
September 26, 2022
From PerkinElmer, Inc.
Via Business Wire
Tickers
PKI
![](https://www.businesswire.com/images/bwlogo_extreme.png)
PerkinElmer Announces Finance Leadership Transition
August 17, 2022
From PerkinElmer, Inc.
Via Business Wire
Tickers
PKI
![](https://mms.businesswire.com/media/20220801005058/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
![](https://mms.businesswire.com/media/20220801005293/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
PerkinElmer Accelerates Transformation into High Growth, High Margin Life Sciences & Diagnostics Company
August 01, 2022
From PerkinElmer, Inc.
Via Business Wire
Tickers
PKI
![](https://mms.businesswire.com/media/20220722005023/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
PerkinElmer Board Declares Quarterly Dividend
July 22, 2022
From PerkinElmer, Inc.
Via Business Wire
Tickers
PKI
![](https://mms.businesswire.com/media/20220722005022/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
![](https://mms.businesswire.com/media/20220714005085/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
![](https://mms.businesswire.com/media/20220621005405/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
![](https://mms.businesswire.com/media/20220607005448/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20220503005043/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
![](https://mms.businesswire.com/media/20220428005199/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
PerkinElmer Board Declares Quarterly Dividend
April 28, 2022
From PerkinElmer, Inc.
Via Business Wire
Tickers
PKI
![](https://www.businesswire.com/images/bwlogo_extreme.png)
PerkinElmer Schedules Earnings Call for Tuesday, May 3, 2022
April 12, 2022
From PerkinElmer, Inc.
Via Business Wire
Tickers
PKI
![](https://mms.businesswire.com/media/20220407005223/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
![](https://mms.businesswire.com/media/20220404005527/en/1409465/5/PKI_Logo.jpg)
![](https://mms.businesswire.com/media/20220216005286/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
![](https://mms.businesswire.com/media/20220210005080/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
PerkinElmer to Present at Citi’s 2022 Virtual Healthcare Conference
February 10, 2022
From PerkinElmer, Inc.
Via Business Wire
Tickers
PKI
![](https://www.businesswire.com/images/bwlogo_extreme.png)
U.S. Centers for Disease Control Guidance Includes EUROIMMUN Assay in its Two-Step Testing Algorithm for Dengue Virus
February 03, 2022
From PerkinElmer, Inc.
Via Business Wire
Tickers
PKI
![](https://mms.businesswire.com/media/20220201005057/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year of 2021
February 01, 2022
From PerkinElmer, Inc.
Via Business Wire
Tickers
PKI
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.